| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Apr―24 |
The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barré syndrome in Japan |
Tomoki Suichi, Sonoko Misawa, Shoko Ukita, Kazumoto Shibuya, Moeko Ogushi, Yasunori Sato, Satoshi Kuwabara |
| 2 |
[GO] |
2025―Oct―05 |
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination |
Roberto Bellanti, Ana Candalija Iserte, Claire Bergstrom Johnson, John Goodfellow, Marina Johnson, Wanwisa Dejnirattisai, Stephen Keddie, Joseph J Campo, Gavin Screaton, David Goldblatt, Michael P Lunn, Alexander J Davies, Simon Rinaldi |
| 3 |
[GO] |
2024―Nov―06 |
Mental health disorders before, during and after the COVID-19 pandemic: a nationwide study |
Clara S Grønkjær, Rune H B Christensen, Daniel Kondziella, Michael E Benros |
| 4 |
[GO] |
2024―Oct―29 |
Correction to: Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations |
|
| 5 |
[GO] |
2024―Oct―08 |
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations |
Catarina Rua, Betty Raman, Christopher T Rodgers, Virginia F J Newcombe, Anne Manktelow, Doris A Chatfield, Stephen J Sawcer, Joanne G Outtrim, Victoria C Lupson, Emmanuel A Stamatakis, Guy B Williams, William T Clarke, Lin Qiu, Martyn Ezra, Rory McDonald, Stuart Clare, Mark Cassar, Stefan Neubauer, Karen D Ersche, Edward T Bullmore, David K Menon, Kyle Pattinson, James B Rowe |
| 6 |
[GO] |
2024―Apr―18 |
Increased frequency and mortality in persons with neurological disorders during COVID-19 |
Candace M Marsters, Jeffrey A Bakal, Grace Y Lam, Finlay A McAlister, Christopher Power |
| 7 |
[GO] |
2024―Apr―01 |
Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects |
Víctor M Serrano del Pueblo, Gemma Serrano-Heras, Carlos M Romero Sánchez, Pepa Piqueras Landete, Laura Rojas-Bartolome, Inmaculada Feria, Richard G M Morris, Bryan Strange, Francisco Mansilla, Linda Zhang, Beatriz Castro-Robles, Lourdes Arias-Salazar, Susana López-López, María Payá, Tomás Segura, Mónica Muñoz-López |
| 8 |
[GO] |
2024―Feb―02 |
Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model |
Troy N Trevino, Avital B Fogel, Guliz Otkiran, Seshadri B Niladhuri, Mark A Sanborn, Jacob Class, Ali A Almousawi, Benoit Vanhollebeke, Leon M Tai, Jalees Rehman, Justin M Richner, Sarah E Lutz |
| 9 |
[GO] |
2023―Nov―09 |
Correction to: Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses |
|
| 10 |
[GO] |
2023―Sep―08 |
Can immunological imprinting drive neurological dysfunction in long COVID? |
Dennis L Kolson |
| 11 |
[GO] |
2023―May―11 |
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses |
Marianna Spatola, Nadège Nziza, Wonyeong Jung, Yixiang Deng, Dansu Yuan, Alessandro Dinoto, Silvia Bozzetti, Vanessa Chiodega, Sergio Ferrari, Douglas A Lauffenburger, Sara Mariotto, Galit Alter |
| 12 |
[GO] |
2023―Feb―02 |
Neuropsychiatric disorders following SARS-CoV-2 infection |
Paul J Harrison, Maxime Taquet |
| 13 |
[GO] |
2023―Jan―16 |
Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection |
Marco Massimo, Carlotta Barelli, Catalina Moreno, Chiara Collesi, Rebecca K Holloway, Berta Crespo, Lorena Zentilin, Anna Williams, Veronique E Miron, Mauro Giacca, Katherine R Long |
| 14 |
[GO] |
2022―Dec―20 |
SARS-CoV-2 targets pericytes to restrict blood flow within the brain |
J Scott Miners, Robert A Fisher, Seth Love |
| 15 |
[GO] |
2022―Nov―03 |
Reply: The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19 |
Myoung-Hwa Lee, Daniel P Perl, Joseph Steiner, Nicholas Pasternack, Wenxue Li, Dragan Maric, Farinaz Safavi, Iren Horkayne-Szakaly, Robert Jones, Michelle N Stram, Joel T Moncur, Marco Hefti, Rebecca D Folkerth, Avindra Nath |
| 16 |
[GO] |
2022―Nov―03 |
The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19 |
Cynthia Magro, Gerard Nuovo |
| 17 |
[GO] |
2022―Oct―06 |
Inflammatory brain injury after severe viral infection is not unique to COVID-19 |
Angelika Bauer, Markus Reindl |
| 18 |
[GO] |
2022―Sep―10 |
Neurological manifestations of COVID-19 in adults and children |
Sung Min Cho, Nicole White, Lavienraj Premraj, Denise Battaglini, Jonathon Fanning, Jacky Suen, Gianluigi Li Bassi, John Fraser, Chiara Robba, Matthew Griffee, Bhagteshwar Singh, Barbara Wanjiru Citarella, Laura Merson, Tom Solomon, David Thomson |
| 19 |
[GO] |
2022―Sep―03 |
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses |
Edward J Needham, Alexander L Ren, Richard J Digby, Emma J Norton, Soraya Ebrahimi, Joanne G Outtrim, Doris A Chatfield, Anne E Manktelow, Maya M Leibowitz, Virginia F J Newcombe, Rainer Doffinger, Gabriela Barcenas-Morales, Claudia Fonseca, Michael J Taussig, Rowan M Burnstein, Romit J Samanta, Cordelia Dunai, Nyarie Sithole, Nicholas J Ashton, Henrik Zetterberg, Magnus Gisslén, Arden Edén, Emelie Marklund, Peter J M Openshaw, Jake Dunning, Michael J Griffiths, Jonathan Cavanagh, Gerome Breen, Sarosh R Irani, Anne Elmer, Nathalie Kingston, Charlotte Summers, John R Bradley, Leonie S Taams, Benedict D Michael, Edward T Bullmore, Kenneth G C Smith, Paul A Lyons, Alasdair J Coles, David K Menon |
| 20 |
[GO] |
2022―Aug―24 |
COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis |
Allison L Soung, Abigail Vanderheiden, Anna S Nordvig, Cheick A Sissoko, Peter Canoll, Madeline B Mariani, Xiaoping Jiang, Traci Bricker, Gorazd B Rosoklija, Victoria Arango, Mark Underwood, J John Mann, Andrew J Dwork, James E Goldman, Adrianus C M Boon, Maura Boldrini, Robyn S Klein |
| 21 |
[GO] |
2022―Jul―22 |
SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction |
Chanawee Hirunpattarasilp, Greg James, Jaturon Kwanthongdee, Felipe Freitas, Jiandong Huo, Huma Sethi, Josef T Kittler, Raymond J Owens, Laura E McCoy, David Attwell |
| 22 |
[GO] |
2022―Jul―18 |
How COVID-19 affects microvessels in the brain |
Jan Wenzel, Markus Schwaninger |
| 23 |
[GO] |
2022―Feb―16 |
COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database |
Ryan Y. S. Keh, Sophie Scanlon, Preeti Datta-Nemdharry, Katherine Donegan, Sally Cavanagh, Mark Foster, David Skelland, James Palmer, Pedro M. Machado, Stephen Keddie, Aisling S. Carr, Michael P. Lunn |
| 24 |
[GO] |
2021―Dec―14 |
Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up |
Sihong Huang, Zhiguo Zhou, Danhui Yang, Wei Zhao, Mu Zeng, Xingzhi Xie, Yanyao Du, Yingjia Jiang, Xianglin Zhou, Wenhan Yang, Hu Guo, Hui Sun, Ping Liu, Jiyang Liu, Hong Luo, Jun Liu |
| 25 |
[GO] |
2021―Aug―13 |
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease |
Erin F Balcom, Avindra Nath, Christopher Power |
| 26 |
[GO] |
2020―Jul―03 |
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings |
Ross W Paterson, Rachel L Brown, Laura Benjamin, Ross Nortley, Sarah Wiethoff, Tehmina Bharucha, Dipa L Jayaseelan, Guru Kumar, Rhian E Raftopoulos, Laura Zambreanu, Vinojini Vivekanandam, Anthony Khoo, Ruth Geraldes, Krishna Chinthapalli, Elena Boyd, Hatice Tuzlali, Gary Price, Gerry Christofi, Jasper Morrow, Patricia McNamara, Benjamin McLoughlin, Soon Tjin Lim, Puja R Mehta, Viva Levee, Stephen Keddie, Wisdom Yong, S Anand Trip, Alexander J M Foulkes, Gary Hotton, Thomas D Miller, Alex D Everitt, Christopher Carswell, Nicholas W S Davies, Michael Yoong, David Attwell, Jemeen Sreedharan, Eli Silber, Jonathan M Schott, Arvind Chandratheva, Richard J Perry, Robert Simister, Anna Checkley, Nicky Longley, Simon F Farmer, Francesco Carletti, Catherine Houlihan, Maria Thom, Michael P Lunn, Jennifer Spillane, Robin Howard, Angela Vincent, David J Werring, Chandrashekar Hoskote, Hans Rolf Jäger, Hadi Manji, Michael S Zandi |
|
